US 8802628
Stable solid formulation of a GC-C receptor agonist polypeptide suitable for oral administration
granted A61KA61K38/10A61K38/12
Quick answer
US patent 8802628 (Stable solid formulation of a GC-C receptor agonist polypeptide suitable for oral administration) held by IRONWOOD PHARMACEUTICALS, INC. expires Mon Aug 07 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- IRONWOOD PHARMACEUTICALS, INC.
- Grant date
- Tue Aug 12 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 07 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 26
- CPC classes
- A61K, A61K38/10, A61K38/12, A61K47/02, A61K47/183